The Effect of Home-Based Walking Program on Peripheral Neuropathy, Fatigue and Quality of Life
NCT ID: NCT06012253
Last Updated: 2025-06-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
88 participants
INTERVENTIONAL
2023-09-15
2024-12-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Self-Management Program Based on the Individual and Family Self-management Theory on Cancer Patients
NCT04822220
Exercise to Reduce Chemotherapy-Induced Peripheral Neuropathy
NCT03515356
Web-Based Exercise for Neuropathy and Quality of Life in Breast Cancer
NCT06879678
Hand-Foot Exercises for Chemotheraphy Induced Peripheral Neuropathy Pain, Falls and Quality of Life in Colorectal Cancer
NCT05873829
The Effect of Walking on Fatigue After Chemotherapy in Patients 65 and Older
NCT02191982
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patient Identification Form, International Physical Activity Questionnaire (IPAQ- Short Form), National Cancer Institute (NCI) -CTCAE v5.0 Toxicity Criteria, Cancer Fatigue Scale, EORTC QLQ-CIPN20 (Quality of Life Chemotherapy-Induced Peripheral Neuropathy) and EORTC QLQ-C30 (Quality of Life Scale), Interview Form will be used to collect data.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Home Based Walking Program
Effect of home-based walking program on peripheral neuropathy, fatigue and quality of life
Home Based Walking Program
The intervention group will be applied to "Home Based Walking Program". It was aimed that the patients should do at least 150 minutes of moderate-intensity physical exercise per week for up to 8 weeks. The content of the program includes a walking information booklet (information notes, activity chart and obstacle avoidance form), exercise diary, face-to-face-telephone counseling, sending text messages, prepared in line with international guides. It was planned to give weekly counseling to the patients included in the intervention group for an 8-week period.
Control group
The control group will be given the "Ministry of Health Physical Activity Guidelines".Routine care.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Home Based Walking Program
The intervention group will be applied to "Home Based Walking Program". It was aimed that the patients should do at least 150 minutes of moderate-intensity physical exercise per week for up to 8 weeks. The content of the program includes a walking information booklet (information notes, activity chart and obstacle avoidance form), exercise diary, face-to-face-telephone counseling, sending text messages, prepared in line with international guides. It was planned to give weekly counseling to the patients included in the intervention group for an 8-week period.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Turkish speaking-understanding ability and literate.
* Orientation (person, place, time)
* Receiving taxane and platinum-based chemotherapy treatment (monotherapy or combined).
* Receiving chemotherapy treatment for the first time.
* The primary medical diagnosis is cancer (breast cancer, colorectal cancers and other cancers).
* Not having health problems that prevent walking.
* Agreeing to participate in the research.
Exclusion Criteria
* Being peripheral neuropathy due to reasons other than chemotherapy (such as chronic disease, diabetes mellitus, nutritional disorders)
* Skin sensitivity on the hands and feet
* Having cardiovascular, pulmonary, musculoskeletal, or psychological disorders that limit exercise or mobility
* Being in another supportive program
* Being in the very active category according to the "International Physical Activity Scale (IPAQ- Short Form)"
* Being a severity of more than 4 points according to the "Modified Borg Scale (MBS)"
* Being a score of 2 and above according to the "ECOG Performance Scale"
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Akdeniz University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hava Kara
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fatma Arikan, PhD, RN
Role: STUDY_DIRECTOR
Akdeniz University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Akdeniz University
Konyaalti, Antalya, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
"70904504/376"
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.